Q3:15 Health Care Deal Volume

by | Oct 26, 2015 9:15 am | Behavioral Health Care, Biotechnology, eHealth, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation

We’re just about to publish our third quarter results this week, but wanted to give you a sneak preview of how the third quarter stacks up against Q2:15 and the same quarter a year ago. Here’s the chart. SectorQ3:15 DealsQ2:15 DealsChangeQ3:14 DealsChange Services Behavioral Health Care10667%4150% Home Health & Hospice9650%15-40% Hospitals332438%1974% Labs, MRI & Dialysis16157%8100% Long-Term Care906538%856% Managed Care12850%5140% Physician Medical Groups1522-32%147% Rehabilitation7617%540% Other Services464015%3628% Services subtotal23819224%19125% Technology Biotechnology413421%27%52% eHealth3334-3%34-3% Medical Devices31297%2619% Pharmaceuticals423811%67-37%... Read More »

GE Healthcare Sells Clarient Lab Business

by | Oct 26, 2015 8:59 am | Laboratories, MRI & Dialysis

GE Healthcare (NYSE: GE)  sold Clarient, Inc. and its wholly owned subsidiary Clarient Diagnostic Services, Inc., which provides comprehensive cancer diagnostic testing to hospitals, physicians and the pharmaceutical industry. The acquirer was NeoGenomics, Inc. (NASDAQ: NEO), which,  together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing labs providing genetic and molecular services. The price, totaling $275,200,000, consists of $80 in cash, $110 million in preferred stock at $7.50 per share, and 15 million shares of NeoGenomics common stock ($85.2 million, based on the prior-day closing price of $5.68 per share). In effect, GE Healthcare... Read More »

Medical Imaging Deals Abound

by | Oct 19, 2015 8:57 am | Laboratories, MRI & Dialysis, Private Equity

Only half way through October, we’ve seen three transactions targeting a medical imaging company in our Laboratories, MRI & Dialysis sector. That brings to 10 the number of imaging targets in 2015, out of the current total of 39 deals recorded in the sector. It began on October 1, with Konica Minolta Medical Imaging USA’s announcement that it was buying Viztek, LLC, a digital software and hardware imaging company, for an undisclosed price. Another optical giant, Toshiba Medical Systems Corporation, announced its acquisition of Olea Medical SA, a French medical imaging applications company, for an undisclosed price. The next day, Digirad Corporation (NASDAQ: DRAD) paid $36... Read More »

Q3:15 Health Care M&A, by Spending

by | Oct 19, 2015 8:56 am | Behavioral Health Care, Biotechnology, eHealth, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Physician Medical Groups, Rehabilitation

Last week we shared our data on health care M&A by sector in the third quarter of 2015. Here’s a look at the same sectors, by share of the dollars spent. If you’ve been following health care M&A at all, you won’t be surprised that the Managed Care sector (health insurers) accounts for about 50% of the $198 billion spent. That total, by the way, is also a new quarterly record. Look for The Health Care M&A Report, Third Quarter, for more in-depth analysis by sector. Read More »

Q3:15 Health Care M&A, By Sector

by | Oct 12, 2015 8:56 am | Behavioral Health Care, Biotechnology, eHealth, Home Health & Hospice, Hospitals, Laboratories, MRI & Dialysis, Long-Term Care, Managed Care, Medical Devices, Other Services, Pharmaceuticals, Rehabilitation

Health care M&A in the third quarter was quite robust, with 385 transations reported across 13 sectors. That’s a new record for any third quarter, by the way. We’ll have the full break-out in The Health Care M&A Report, Third Quarter 2015, due to be published by the end of this month. In the meantime, here’s how the sectors fared in Q3:15. Read More »

Signal Bay Buys Cannabis Testing Lab

by | Sep 28, 2015 8:56 am | Laboratories, MRI & Dialysis

The medical marijuana market has been growing like a weed, puns intended, but we haven’t logged many deals associated with it because they’re either undisclosed or simply too far afield to qualify. Last week, however, Las Vegas-based Signal Bay Inc. announced its acquisition of Bend, Oregon-based CannAlytical Research, a testing laboratory that is equipped with the latest high-performance liquid chromatography equipment. It provides state-mandated compliance tests for licensed medical marijuana dispensaries. Signal Bay, through its wholly owned subsidiaries Signal Bay Research, Inc. and Signal Bay Services, Inc., provides industry research, consulting, license application support and... Read More »